Comment on

• Anticoagulation and neuraxial block: historical perspective, anesthetic implications, and risk management.

  Horlocker TT, Wedel DJ. Horlocker TT, et al. Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):129-34. doi: 10.1016/s1098-7339(98)90137-7. Reg Anesth Pain Med. 1998. PMID: 9845384 Review. No abstract available.
• Low-molecular-weight heparin: biochemistry, pharmacology, and concurrent drug precautions.

  Heit JA. Heit JA. Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):135-9. doi: 10.1016/s1098-7339(98)90138-9. Reg Anesth Pain Med. 1998. PMID: 9845385 Review. No abstract available.
• Oral anticoagulants and regional anesthesia: a perspective.

  Enneking FK, Benzon H. Enneking FK, et al. Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):140-5. doi: 10.1016/s1098-7339(98)90139-0. Reg Anesth Pain Med. 1998. PMID: 9845386 Review. No abstract available.
• Statistics: detecting a rare adverse drug reaction using spontaneous reports.

  Schroeder DR. Schroeder DR. Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):183-9. doi: 10.1016/s1098-7339(98)90145-6. Reg Anesth Pain Med. 1998. PMID: 9845392 No abstract available.
• Monitoring adverse drug events: the Food and Drug Administration MedWatch reporting system.

  Landow L. Landow L. Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):190-3. doi: 10.1016/s1098-7339(98)90146-8. Reg Anesth Pain Med. 1998. PMID: 9845393 No abstract available.